Simultaneous evaluation of the harms and benefits of treatments in randomized clinical trials: Demonstration of a new approach

Psychological Medicine

Volumn 42, Issue 4, 2012, Pages 865-873

  Frank, E ^a   Kupfer, D J ^a   Rucci, P ^a   Lotz Wallace, M ^a   Levenson, J ^a   Fournier, J ^a   Kraemer, H C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Harm benefit balance; personalized treatment; RCTs; treatment outcome

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM;

ADULT; ARTICLE; CONFIDENCE INTERVAL; DEPRESSION; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; PHARMACOKINETICS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICS;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; CONFIDENCE INTERVALS; DATA INTERPRETATION, STATISTICAL; DEPRESSIVE DISORDER; FEMALE; HUMANS; INDIVIDUALIZED MEDICINE; MALE; MIDDLE AGED; MODELS, STATISTICAL; OBSERVER VARIATION; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THERAPEUTIC EQUIVALENCY;

EID: 84858766615     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291711001619     Document Type: Article

References (21)

1. APA (2000). Handbook of Psychiatric Measures, 1st edn. American Psychiatric Association: Washington, DC.
2. BrownW(1910). Some experimental results in the correlation of mental abilities. British Journal of Psychology 3, 296-322.
3. Cassano GB, Michelini S, Shear MK, Coli E, Maser JD, Frank E (1997). The panic-agoraphobic spectrum: a descriptive approach to the assessment and treatment of subtle symptoms. American Journal of Psychiatry 154, 27-38. (Pubitemid 27225244)
4. Cohen J (1988). Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum Associates: Hillsdale, NJ.
5. Detre KA, Wright E, Murphy ML, Takaro T (1975). Observer agreement in evaluating coronary angiograms. Circulation 52, 979-986.
6. Efron B (1988). Bootstrap confidence intervals: good or bad? Psychological Bulletin 104, 293-296.
7. Frank E, Cassano GB, Rucci P, Thompson WK, Kraemer HC, Fagiolini A, Maggi L, Kupfer DJ, Shear MK, Houck PR, Calugi S, Grochocinski VJ, Scocco P, Buttenfield J, Forgione RN (2011). Predictors and moderators of time to remission of depression with interpersonal psychotherapy and SSRI pharmacotherapy. Psychological Medicine 41, 151-162.
8. Frank E, Cassano GB, Shear MK, Rotondo A, Dell'Osso L, Mauri M, Maser J, Grochocinski V (1998). The spectrum model: a more coherent approach to the complexity of psychiatric symptomatology. CNS Spectrums 3, 23-34. (Pubitemid 29122693)
9. Goldberg LR (1970). Man versus model of man: a rationale, plus some evidence, for a method of improving on clinical inferences. Psychological Bulletin 73, 422-432.
10. Grove WM, Meehl PE (1996). Comparative efficiency of informal (subjective, impressionistic) and formal (mechanical, algorithmic) prediction procedures: the clinical-statistical controversy. Psychology, Public Policy, and Law 2, 293-323. (Pubitemid 126408878)
11. Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 23, 56-62.
12. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, Sanislow C, Wang P (2010). Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. American Journal of Psychiatry 167, 748-751.
13. Karelaia N, Hogarth RM (2008). Determinants of linear judgment: a meta-analysis of lens model studies. Psychological Bulletin 134, 404-426.
14. Klerman GL, Weissmann MM, Rounsaville BJ, Chevron ES (1984). Interpersonal Psychotherapy of Depression. Basic Books: New York, NY.
15. Kraemer HC (1979). Ramifications of a population model for k as a coefficient of reliability. Psychometrika 44, 461-472.
16. Kraemer HC, Frank E (2010). Evaluation of comparative treatment trials: assessing the clinical benefits and risks for patients, rather than statistical effects on measures. Journal of the American Medical Association 304, 683-684.
17. Kraemer HC, Frank E, Kupfer DJ (2011). How to assess the clinical impact of treatments on patients, rather than the statistical impact of treatments on measures. International Journal of Methods in Psychiatric Research 20, 63-72.
18. Kraemer HC, Kupfer DJ (2006). Size of treatment effects and their importance to clinical research and practice. Biological Psychiatry 59, 990-996. (Pubitemid 43849650)
19. Kraemer HC, Thiemann S (1987). How Many Subjects? Statistical Power Analysis in Research. Sage Publications: Newbury Park, CA.
20. Rush AJ, O'Neal (1999). Patient Rated Inventory of Side Effects (PRISE). Unpublished rating scale. University of Texas Southwestern Medical Center: Dallas, TX.
21. Spearman C (1910). Correlation calculated from faulty data. Britsish Journal of Psychology 3, 271-295.